Loading organizations...
Loading organizations...
Biopharmaceutical company enhancing monoclonal antibodies for cancer treatm
ImmuneXcite has raised $12.2M across 2 funding rounds.
ImmuneXcite has raised $12.2M in total across 2 funding rounds.
ImmuneXcite has raised $12.2M in total across 2 funding rounds.
ImmuneXcite's investors include Cormorant Asset Management, Partners Innovation Fund, Ann DeWitt.
ImmuneXcite has raised $12.2M across 2 funding rounds. Most recently, it raised $8.6M Series A in March 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 30, 2016 | $8.6M Series A | Cormorant Asset Management, Partners Innovation Fund, Ann DeWitt | |
| Jan 8, 2014 | $3.6M Series B |